Blueprint Medicines Appoints Percy Carter, MBA, Ph.D., as Chief Scientific Officer
- Monday, May 17, 2021, 7:07
- Business
- Add a comment
CAMBRIDGE, Mass., May 17, 2021 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the appointment of Percy Carter, MBA, Ph.D., as Chief Scientific Officer, effective May 19, 2021. In this role, Dr. Carter will oversee all of the company’s research and…
About the Author
adminasapcorp has written 41806 stories on this site.